Cite
HARVARD Citation
Chen, P. et al. (2019). Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy. Journal of the Chinese Medical Association. 82 (1), p. . [Online].